Last Updated: November 8, 2026

SORBITOL-MANNITOL Drug Patent Profile

« Back to Dashboard


Which patents cover Sorbitol-mannitol, and when can generic versions of Sorbitol-mannitol launch?

Sorbitol-mannitol is a drug marketed by Hospira and Otsuka Icu Medcl and is included in three NDAs.

The generic ingredient in SORBITOL-MANNITOL is mannitol; sorbitol. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the mannitol; sorbitol profile page.

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for SORBITOL-MANNITOL?
  • What are the global sales for SORBITOL-MANNITOL?
  • What is Average Wholesale Price for SORBITOL-MANNITOL?
Summary for SORBITOL-MANNITOL
US Patents:0
Applicants:2
NDAs:3
Raw Ingredient (Bulk) Api Vendors: 149
Clinical Trials: 2
What excipients (inactive ingredients) are in SORBITOL-MANNITOL?SORBITOL-MANNITOL excipients list
DailyMed Link:SORBITOL-MANNITOL at DailyMed
Recent Clinical Trials for SORBITOL-MANNITOL

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
PfizerPhase 1
Brigitte Jolles, MDPhase 2/Phase 3

See all SORBITOL-MANNITOL clinical trials

US Patents and Regulatory Information for SORBITOL-MANNITOL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira SORBITOL-MANNITOL mannitol; sorbitol SOLUTION;IRRIGATION 080224-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Hospira SORBITOL-MANNITOL IN PLASTIC CONTAINER mannitol; sorbitol SOLUTION;IRRIGATION 017636-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Otsuka Icu Medcl SORBITOL-MANNITOL IN PLASTIC CONTAINER mannitol; sorbitol SOLUTION;IRRIGATION 018316-001 Approved Prior to Jan 1, 1982 RX Yes Yes ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.